Patents by Inventor Vaclav Stepanek

Vaclav Stepanek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180053638
    Abstract: A plasma generator is located outside the vacuum chamber and generates neutral reactive particles and charged particles. A magnet positioned outside the plasma generator deflects the charged particles, preventing some or all of them from entering the vacuum chamber, thereby preventing secondary plasma sources from forming in the vacuum chamber, while allowing neutral reactive particles to enter the vacuum chamber to reduce contamination. Associated methods are also described.
    Type: Application
    Filed: August 16, 2017
    Publication date: February 22, 2018
    Inventors: Viktor Svéda, Libor Novák, Václav Stepánek, Pavel Poloucek
  • Patent number: 8039604
    Abstract: The invention consists in a nucleotide sequence having the size of (2646) bp, wherein the order of nucleotides is identical to the order of the nucleotide sequence encoding penicillin acylase from Achromobacter sp. CCM 4824 (formerly Comamonas testosteroni CCM 4824), eventually of the fragments of this sequence having the length of at least 150 nucleotides. The sequence can be used in the formation of a DNA construct, eventually the construct having at least one regulatory sequence regulating the expression of the gene and the production of a polypeptide with the penicillin acylase activity. The sequence can form part of a recombinant expression vector, which consists of the above-mentioned construct, promoter, translational start signal, translational and transcriptional stop signal. Further, the invention concerns a recombinant host cell, containing the nucleic acid construct carried by the vector or integrated into the cell chromosome, and the E.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: October 18, 2011
    Assignees: Fermenta Biotech Limited, Mikrobiologicky UTSAV AV CR
    Inventors: Pavel Kyslik, Vaclav Stepanek, Lenka Hollerova, Stanislav Becka, Vyasarayani Williams Rajasekar, Datla Anupama, Kamila Plhackova, Jaroslav Marsalek
  • Publication number: 20100112673
    Abstract: The invention consists in a nucleotide sequence having the size of (2646) bp, wherein the order of nucleotides is identical to the order of the nucleotide sequence encoding penicillin acylase from Achromobacter sp. CCM 4824 (formerly Comamonas testosteroni CCM 4824), eventually of the fragments of this sequence having the length of at least 150 nucleotides. The sequence can be used in the formation of a DNA construct, eventually the construct having at least one regulatory sequence regulating the expression of the gene and the production of a polypeptide with the penicillin acylase activity. The sequence can form part of a recombinant expression vector, which consists of the above-mentioned construct, promoter, translational start signal, translational and transcriptional stop signal. Further, the invention concerns a recombinant host cell, containing the nucleic acid construct carried by the vector or integrated into the cell chromosome, and the E.
    Type: Application
    Filed: May 15, 2007
    Publication date: May 6, 2010
    Applicants: Fermenta Biotech Limited, Mikrobiologicky UTSAV AV CR v.v.i.
    Inventors: Pavel Kyslik, Vaclav Stepanek, Lenka Hollerova, Stanislav Becka, Vyasarayani Williams Rajasekar, Datla Anupama, Kamila Plhackova, Jaroslav Marsalek